Navigation Links
Dynamics Research Corporation Awarded $11.4 Million Medical Healthcare Program Management Contract
Date:11/5/2008

ANDOVER, Mass., Nov. 5 /PRNewswire-FirstCall/ -- Dynamics Research Corporation (Nasdaq: DRCO), a leading provider of innovative management consulting, engineering, technology and information technology services and solutions to federal and state governments, announced today that it received an $11.4 million task order under the TRICARE Evaluation, Analysis, Management and Support (TEAMS) indefinite delivery and indefinite quantity (ID/IQ) contract, to provide program management support to the traumatic brain injury and psychological health program. The task order, which is under the Office of the Assistant Secretary of Defense for Health Affairs and TRICARE Management Activity, has a one-year base period with four option years.

"DRC is honored to apply our program management expertise on this critical program to support our injured soldiers," said James P. Regan, DRC's chairman, president and CEO. "This first task order under TEAMS provides another important customer in this the DOD health sector, an area we have targeted for growth."

DRC will assist in the coordination of projects, initiatives, and activities in support of implementing the recommendations and requirements within the purview of the Force Health Protection and Policy Programs Directorate. The objectives include improving program coordination, managing funds/budgeting tasks, develop scheduling, streamlining information handling/sharing, monitoring program performance and managing projects portfolio.

DRC was one of 23 companies awarded the TEAMS contract with a total ceiling value of $5 billion. The TEAMS contract provides the Military Health System (MHS) with the ability to order services for its organizational conflict of interest (OCI) Category 2 non-purchased care support needs. This contract has a term of a single base year and nine option years. DRC was selected for the TEAMS vehicle Category 2, Program Management Support, due to extensive management services expertise and proven performance supporting defense, national security and civilian government.

About Dynamics Research Corporation

Dynamics Research Corporation (DRC) is a leading provider of mission-critical technology management services and solutions for government programs. DRC offers forward-thinking solutions backed by a history of excellence and customer satisfaction. Founded in 1955, DRC is a publicly held corporation (Nasdaq: DRCO) and maintains more than 25 offices nationwide with major offices in Andover, Massachusetts; Reston, Virginia; and Fairborn, Ohio. For more information please visit our website at http://www.drc.com.

Safe harbor statements under the Private Securities Litigation Reform Act of 1995: Some statements contained or implied in this news release, may be considered forward-looking statements, which by their nature are uncertain. Consequently, actual results could materially differ. For more detailed information concerning how risks and uncertainties could affect the company's financial results, please refer to DRC's most recent filings with the SEC. The company assumes no obligation to update any forward-looking information.

CONTACTS: Investors: Chris Witty Media: Marisa Hagerman

Darrow Associates, Inc. Sage Communications

646.438.9385 703.584.5637

cwitty@darrowir.com marisah@aboutsage.com


'/>"/>
SOURCE Dynamics Research Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. General Dynamics Honored with the 2008 Outstanding Contractor Award by the Administration for Children and Families
2. Air Methods Awarded $15 Million Contract From General Dynamics Land Systems
3. CardioDynamics Reports Second Fiscal Quarter 2008 Results, 18% Revenue Increase for First Half 2008
4. CardioDynamics Announces Second Quarter 2008 Conference Call and Webcast
5. General Dynamics Awarded Multiple Contracts to Support Defense Medical Logistics Supply Chain Operations
6. HLTH Announces Agreement to Sell ViPS Unit to General Dynamics for $225 Million
7. CardioDynamics Announces Significant ICG Study with Nearly Three Times the National Average Blood Pressure Control Rates at the American Society for Hypertension Annual Scientific Meeting
8. CardioDynamics Reports 22% Revenue Growth in First Quarter 2008
9. Asset-Recovery Leader Chooses Microsoft Dynamics AX and CRM Online
10. General Dynamics Itronix Donates Computers to Humanitarian Expedition Fighting Malaria in Africa
11. CardioDynamics Board of Directors Proposes Reverse Split 1:7 of Companys Shares
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... Olathe, KS (PRWEB) , ... April 28, 2017 ... ... system have typically been previously exposed to more adverse experiences than children in ... have experienced trauma such as abuse, neglect or other family challenges. While no ...
(Date:4/28/2017)... ... April 28, 2017 , ... Early ... substantially improve drug safety and minimize the cost of development. In this webinar, ... inhibition using cell lines and for cardiac toxicity using induced pluripotent stem cells ...
(Date:4/28/2017)... ... April 28, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of ... the Creator responds to and which He does not. Yisrayl says with so many ... is the true name, but he says with a little Scripture, backed with a lot ...
(Date:4/28/2017)... ... 2017 , ... Intellitec Solutions announced the publication of a ... Dynamics GP solution that integrates to their PointClickCare EHR software package. With the ... Brooke Grove now has the capability to achieve its goal for a comprehensive ...
(Date:4/28/2017)... ... April 28, 2017 , ... Rob Lowe is a popular actor that ... his presence to an educational purpose as the host of the “Informed” series. The ... In a recent episode, the series focuses on thyroid cancer. , Although thyroid cancer ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017 Research and Markets ... - Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage ... offering. ... drug delivery technologies will rise from USD 20 Billion in 2015 ... Global Drug Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables ...
(Date:4/20/2017)...  AbbVie (NYSE: ABBV), a global biopharmaceutical company, ... hepatitis C virus (HCV) infected patients with genotype ... cirrhosis (Child-Pugh A) achieved sustained virologic response at ... investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high ... weeks of G/P treatment without ribavirin. Patients with ...
(Date:4/20/2017)... LUND, Sweden , April 20, 2017 /PRNewswire/ ... OTCQX: NEVPF) ("NeuroVive") today announced positive preclinical ... company,s preclinical compound for non-alcoholic steatohepatitis (NASH), ... NV556 has previously ... STAM™ NASH model. Today, NeuroVive,s scientists present ...
Breaking Medicine Technology: